Skip to main content

Abstract

The assessment of health outcomes is rapidly evolving, with a growing interest in outcomes reported by the patient. Patient-reported outcomes (PROs) constitute any report of the status of a patient’s health condition that comes directly from the patient without any interpretation of the patient’s response by a clinician or anyone else (US Food and Drug Administration 2009). Examples include patient’s report of their symptoms, physical function or patient satisfaction. However, emphasis on the patient’s own self-report has increased in the last two decades.

Living with a Chronic Disease

(Anecdote)

Having a chronic illness, Molly thought, was like being invaded. Her grandmother back in Michigan used to tell about the day one of their cows got loose and wandered into the parlor, and the awful time they had getting her out. That was exactly what Molly’s arthritis was like: as if some big old cow had got into her house and wouldn't go away. It just sat there, taking up space in her life and making everything more difficult, mooing loudly from time to time and making cow pies, and all she could do really was edge around it and put up with it.

When other people first became aware of the cow, they expressed concern and anxiety. They suggested strategies for getting the animal out of Molly's parlor: remedies and doctors and procedures, some mainstream and some New Age. They related anecdotes of friends who had removed their own cows in one way or another. But after a while they had exhausted their suggestions. Then they usually began to pretend that the cow wasn't there, and they preferred for Molly to go along with the pretense.

Alison Lurie, The Last Resort

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Basch E (2013) Toward patient-centered drug development in oncology. N Engl J Med 369(5):397–400

    Article  CAS  PubMed  Google Scholar 

  • Basra MKA, Shahrukh M (2009) Burden of skin diseases. Expert Rev Pharmacoecon Outcomes Res 9(3):271–283

    Article  PubMed  Google Scholar 

  • Bertsias G et al (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67(2):195–205

    Article  CAS  PubMed  Google Scholar 

  • Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ 346:f167

    Article  PubMed  Google Scholar 

  • Bottomley A et al (2009) Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer 45(3):347–353

    Article  PubMed  Google Scholar 

  • Coons SJ et al (2011) The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther 90(5):743–748

    Article  CAS  PubMed  Google Scholar 

  • Department of Health (2014) Title: the NHS outcomes framework 2015/16. Department of Health, London, pp 1–22

    Google Scholar 

  • Devlin NJ, Appleby J (2010) Getting the most out of PROMS. The Kings Fund, Office of Health Economics, London

    Google Scholar 

  • Doward LC et al (2010) Patient reported outcomes: looking beyond the label claim. Health Qual Life Outcomes 8:89

    Article  PubMed  PubMed Central  Google Scholar 

  • Gladman DD et al (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30(9):1955–1959

    PubMed  Google Scholar 

  • Gnanasakthy A et al (2013) Potential of patient-reported outcomes as nonprimary endpoints in clinical trials. Health Qual Life Outcomes 11(1):83

    Article  PubMed  PubMed Central  Google Scholar 

  • Gnanasakthy A et al (2016) Patient-reported outcomes labeling for products approved by the office of hematology and oncology products of the US Food and Drug Administration (2010–2014). J Clin Oncol 34(16):1928–1934

    Article  CAS  PubMed  Google Scholar 

  • Greenhalgh J (2009) The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res 18(1):115–123

    Article  PubMed  Google Scholar 

  • Grob JJ (2007) Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? J Investig Dermatol 127(10):2299–2301

    Article  CAS  PubMed  Google Scholar 

  • Hermansen SE et al (2002) Patients’ and doctors’ assessment of skin disease handicap. Clin Exp Dermatol 27(3):249–250

    Article  CAS  PubMed  Google Scholar 

  • Jemec GB, Wulf HC (1996) Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol 21(3):177–179

    Article  CAS  PubMed  Google Scholar 

  • Kluetz PG et al (2016) Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res 22(7):1553–1558

    Article  CAS  PubMed  Google Scholar 

  • Lisnevskaia L et al (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888

    Article  PubMed  Google Scholar 

  • Lohr KN, Zebrack BJ (2009) Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res 18(1):99–107

    Article  PubMed  Google Scholar 

  • Luckett T et al (2009) Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology 18(11):1129–1138

    Article  CAS  PubMed  Google Scholar 

  • McKenna SP (2011) Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med 9(1):86

    Article  PubMed  PubMed Central  Google Scholar 

  • Nijsten T (2012) Dermatology Life Quality Index: time to move forward. J Investig Dermatol 132(1):11–13

    Article  CAS  PubMed  Google Scholar 

  • Padilla GV et al (1996) Quality of life - cancer. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadelphia, pp 301–308

    Google Scholar 

  • Reeve BB et al (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 106(7):pii: dju129

    Article  Google Scholar 

  • Renzi C et al (2001) Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 145(4):617–623

    Article  CAS  PubMed  Google Scholar 

  • Robinson D, Aguilar D (2010) Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis care Res 62(2):266–273

    Article  Google Scholar 

  • Salek M (1998) Compendium of quality of life instruments. Euromed Communications, Haslemere

    Google Scholar 

  • Salek MS, Luscombe DK (1992) Health-related quality of life assessment: a review. J Drug Dev 5(3):137–153

    Google Scholar 

  • Schmitt J, Ford DE (2007) Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis – a structural equations modeling approach. Gen Hosp Psychiatry 29(2):134–140

    Article  PubMed  Google Scholar 

  • Sutanto B et al (2013) Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res 65(11):1752–1765

    Article  Google Scholar 

  • US Food and Drug Administration (2009) Guidance for Industry: Patient-reported outcome measures: use in medicinal product development to support labeling claims. Health Qual Life Outcomes 4:79

    Google Scholar 

  • World Health Organisation (2014) Global health estimates 2014 summary tables: DALY by cause, age and sex, by WHO Regio, 2000–2012. World Health Organisation, Geneva

    Google Scholar 

  • Wörle B et al (2007) Definition and treatment of primary hyperhidrosis. J German Soc Dermatol 5(7):625–628

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kamudoni, P., Johns, N., Salek, S. (2018). Overview. In: Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Adis, Singapore. https://doi.org/10.1007/978-981-10-8414-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8414-0_1

  • Published:

  • Publisher Name: Adis, Singapore

  • Print ISBN: 978-981-10-8413-3

  • Online ISBN: 978-981-10-8414-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics